Display Settings:

Format

Send to:

Choose Destination

    Neuroreport. 1999 Nov 26;10(17):3675-80.

    Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.

    Aguirre N, Barrionuevo M, Ramírez MJ, Del Río J, Lasheras B.

    Department of Pharmacology, School of Medicine, University of Navarra, Pamplona, Spain.

    A single administration of 3,4-methylenedioxymethamphetamine (MDMA, 20 mg/kg, i.p.), induced significant hyperthermia in rats and reduced 5-hydroxytryptamine (5-HT) content and [3H]paroxetine-labeled 5-HT transporter density in the frontal cortex, striatum and hippocampus by 40-60% 1 week later. MDMA treatment also increased glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus. Repeated administration of the metabolic antioxidant alpha-lipoic acid (100 mg/kg, i.p., b.i.d. for 2 consecutive days) 30 min prior to MDMA did not prevent the acute hyperthermia induced by the drug; however, it fully prevented the serotonergic deficits and the changes in the glial response induced by MDMA. These results further support the hypothesis that free radical formation is responsible for MDMA-induced neurotoxicity.

    PMID: 10619665 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Paroxetine (Paxil®, Paxil® CR, Pexeva®)

      Paroxetine tablets, suspension (liquid), and extended-release (long-acting) tablets are used to treat depression, panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks), and social anxi...